Short Interest Filing: CANNIBICS PHARMACEUT (OTCMKTS:CNBX) Has Increase in Shorts

November 30, 2016 - By Adrian Mccoy   ·   0 Comments

Short Interest Filing: CANNIBICS PHARMACEUT (OTCMKTS:CNBX) Has Increase in Shorts

The stock of CANNIBICS PHARMACEUT (OTCMKTS:CNBX) registered an increase of 0.34% in short interest. CNBX’s total short interest was 29,700 shares in November as published by FINRA. Its up 0.34% from 29,600 shares, reported previously. The stock decreased 9.94% or $0.07 on November 29, hitting $0.63. About 145,591 shares traded hands. Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) has risen 687.50% since April 27, 2016 and is uptrending. It has outperformed by 682.27% the S&P500.

Cannabics Pharmaceuticals Inc., formerly American Mining Company, is a biotechnology pharmaceutical company. The company has a market cap of $69.45 million. The Firm is engaged in pharmaceutical development. It currently has negative earnings. The Firm is focused on development and licensing of cannabinoid treatments and therapies.

CNBX Company Profile

Cannabics Pharmaceuticals Inc., formerly American Mining Company, incorporated on September 15, 2004, is a biotechnology pharmaceutical company. The Firm is engaged in pharmaceutical development. The Firm is focused on development and licensing of cannabinoid treatments and therapies. It develops and markets various therapies and biotechnological tools aimed at providing relief from ailments that respond to active ingredients sourced from the cannabis plant. These tools include delivery systems for cannabinoids, personalized medicine therapies and procedures based on cannabis originated compounds, and bioinformatics tools. The Company’s flagship product is CANNABICS SR. CANNABICS SR a technology for a long acting oil capsule that provides administration of cannabis. CANNABICS SR is composed solely from food grade materials and delivers effects for over 10 to 12 hours. CANNABICS SR is indicated initially as a palliative care therapy for cancer patients. The delivery method enables a once per day dosing regimen of medical cannabis to patients.

More notable recent Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) news were published by: Prnewswire.com which released: “Cannabics Pharmaceuticals Announces Start of Clinical Study in Israel for …” on March 22, 2016, also Prnewswire.com with their article: “Cannabics Pharmaceuticals Files Patent Application for the Company’s Slow …” published on February 24, 2016, Prnewswire.com published: “Cannabics Pharmaceuticals Places IP & Subsidiary Within the Company” on February 29, 2016. More interesting news about Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) were released by: Prnewswire.com and their article: “Cannabics Pharmaceuticals Inc. Announces New Access of Cannabics Oil Capsules …” published on September 08, 2015 as well as Prnewswire.com‘s news article titled: “Cannabics Pharmaceuticals Inc. Announces Increasing Sales of WanaCapsXR …” with publication date: August 13, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Adrian Mccoy


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>